| Fiscal Period | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Period End Date | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
| Total Liabilities Shareholders' Equity | 2,574.68 | 2,432.36 | 2,421.40 | 2,207.96 |
| Accumulated Depreciation Total | -628.00 | -576.67 | -528.54 | -482.13 |
| Cash Equivalents | 4.58 | 6.74 | 7.50 | - |
| Other Liabilities Total | 4.49 | 2.91 | 3.20 | 18.79 |
| Accrued Expenses | 4.29 | 2.95 | 4.37 | 4.73 |
| Long Term Debt | 284.00 | 275.33 | 204.68 | 138.50 |
| Common Stock Total | 91.27 | 91.94 | 92.60 | 92.60 |
| Other Equity Total | 10.50 | 8.91 | 8.85 | 9.84 |
| Other Current Assets Total | 81.45 | 109.77 | 89.93 | 0.72 |
| Total Assets | 2,574.68 | 2,432.36 | 2,421.40 | 2,207.96 |
| Current Portof LT Debt/ Capital Leases | 57.59 | 73.33 | 403.83 | 46.10 |
| Total Equity | 1,369.00 | 1,281.55 | 1,192.43 | 1,036.36 |
| Long Term Investments | 22.41 | 19.97 | 18.80 | 19.48 |
| Retained Earnings( Accumulated Deficit) | 1,267.23 | 1,180.71 | 1,090.99 | 933.92 |
| Total Common Shares Outstanding | 9.13 | 9.19 | 9.26 | 9.26 |
| Property/ Plant/ Equipment Total- Gross | 1,761.11 | 1,611.81 | 1,390.79 | 1,248.65 |
| Tangible Book Valueper Share Common Eq | 143.07 | 135.39 | 126.14 | 111.90 |
| Total Liabilities | 1,205.68 | 1,150.81 | 1,228.96 | 1,171.60 |
| Total Debt | 615.07 | 564.28 | 608.91 | 542.82 |
| Short Term Investments | 17.00 | 13.07 | 12.21 | 13.92 |
| Cashand Short Term Investments | 21.57 | 19.82 | 19.71 | 34.25 |
| Total Receivables Net | 762.41 | 705.24 | 865.85 | 832.46 |
| Notes Payable/ Short Term Debt | 271.84 | 214.70 | 0.00 | 356.34 |
| Deferred Income Tax | 78.23 | 75.71 | 70.97 | 72.43 |
| Accounts Receivable- Trade Net | 751.18 | 704.55 | 864.84 | 749.90 |
| Property/ Plant/ Equipment Total- Net | 1,133.10 | 1,035.14 | 862.24 | 766.52 |
| Minority Interest | 0.34 | 0.41 | 0.23 | -0.06 |
| Total Current Liabilities | 836.97 | 795.54 | 949.48 | 940.06 |
| Total Inventory | 472.93 | 485.89 | 516.29 | 525.94 |
| Accounts Payable | 416.14 | 425.49 | 480.27 | 468.67 |
| Other Currentliabilities Total | 87.12 | 79.06 | 61.01 | 64.21 |
| Total Long Term Debt | 285.65 | 276.24 | 205.08 | 140.38 |
| Intangibles Net | 63.19 | 36.82 | 24.33 | 0.15 |
| Other Long Term Assets Total | 0.82 | 0.00 | 0.00 | 0.00 |
| Note Receivable- Long Term | 16.80 | 19.70 | 24.23 | 28.44 |
| period Length | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Assets | 1,338.36 | 1,320.72 | 1,491.79 | 1,393.37 |
| Capital Lease Obligations | 1.65 | 0.91 | 0.40 | 1.88 |
| Cash | - | - | - | 20.33 |
Aarti Drugs Dividend Aarti Drugs Bonus Aarti Drugs News Aarti Drugs AGM Aarti Drugs Rights Aarti Drugs Splits Aarti Drugs Board Meetings Aarti Drugs Key Metrics Aarti Drugs Shareholdings Aarti Drugs Profit Loss Aarti Drugs Cashflow Aarti Drugs Q1 Results Aarti Drugs Q2 Results Aarti Drugs Q3 Results Aarti Drugs Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks